Neurogene Inc (NGNE) support and resistance · $286.5M cap
Neurogene Inc (NGNE) is a biotechnology company listed on US.
This page maps Neurogene Inc (NGNE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NGNE revenue for 2025-09-30 was $0. Net income was -$21.0M. NGNE currently screens at market cap $286.5M.
NGNE currently screens at market cap $286.5M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NGNE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NGNE quote page for the session range and the stock page for the full model.
Not investment advice.